Cancer Research Cancer Research Funding Available  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 54, 2560-2562, May 15, 1994]
© 1994 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Davies, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davies, S. M.

Developmental Regulation of Genomic Imprinting of the IGF2 Gene in Human Liver1

Stella M. Davies2

Divisions of Pediatric Hematology and Oncology and Bone Marrow Transplantation, University of Minnesota, Minneapolis, Minnesota 55455

Control of the expression of the human insulin-like growth factor II gene is known to be complex, displaying both tissue-specific and developmental regulation. Insulin-like growth factor II is expressed at high levels in most tissues in the human fetus and appears to be important in fetal growth. In adult life, high levels of expression are found chiefly in liver, kidney, skin, nerve, and muscle tissue. Recent studies in the human fetus have demonstrated that in all tissues examined, including liver, the human insulin-like growth factor II gene is imprinted, with the paternally inherited allele expressed and the maternally inherited allele silent. The present study demonstrates that while the insulin-like growth factor gene is imprinted in human fetal liver, imprinting is relaxed in the second half of the first year of postnatal life, and thereafter the insulin-like growth factor gene is biallelically expressed.

1 This study was funded by the Children's Cancer Research Fund, the Viking's Children's Fund, and NIH Grant NO1-DK-6-2274.

2 To whom requests for reprints should be addressed, at University of Minnesota, Hematology/Oncology Division, Department of Pediatrics, Box 484, 420 Delaware Street S. E., Minneapolis, MN 55455.

Received 3/ 9/94. Accepted 4/ 5/94.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
E. A. Lawson, X. Zhang, J. T. Crocker, W.-L. Wang, and A. Klibanski
Hypoglycemia from IGF2 Overexpression Associated with Activation of Fetal Promoters and Loss of Imprinting in a Metastatic Hemangiopericytoma
J. Clin. Endocrinol. Metab., July 1, 2009; 94(7): 2226 - 2231.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
C. Curchoe, S. Zhang, Y. Bin, X. Zhang, L. Yang, D. Feng, M. O'Neill, and X. C. Tian
Promoter-Specific Expression of the Imprinted IGF2 Gene in Cattle (Bos taurus)
Biol Reprod, December 1, 2005; 73(6): 1275 - 1281.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1994 by the American Association for Cancer Research.